Biomarker Testing Services - Neurological Disorders

The human nervous system, intricately woven into every aspect of our existence, falls prey to a vast array of neurological disorders. These conditions--Alzheimer's disease, Parkinson's disease, multiple sclerosis, and countless others--manifest in a multitude of ways, impacting movement, speech, cognition, and beyond. Complications associated with these disorders can be devastating, ranging from memory loss and tumors to seizures, paralysis, and even coma. The sheer complexity of the nervous system and the often-intertwined mechanisms of these disorders pose significant challenges in diagnosis, treatment, and finding cures.

Identifying and employing neurologically relevant and disease-specific biomarkers are critical not only in drug discovery, drug development, and clinical trials, but also in clinical practice--for accurate diagnosis & prognosis and to establish a recommended course of treatment. Biomarker variability based on demography, race, and ethnicity should also be considered when designing appropriate assay panels.

Scalable and sensitive assays that accurately detect early markers are crucial for the early detection of neurological disorders, most of which are irreversible. Developing assays designed with reagents that account for the biological intricacies of biomarkers is critical to advance research and properly diagnose and predict neurological disease. Faced with the challenges of understanding the mechanism of action of even the most prevalent neurological disorders, it is important to employ a broad spectrum of relevant biomarker panels and sensitive assays.